Levo Gen 2 Clinical Network

An innovative tinnitus solution, scientifically validated and ready to be integrated into your clinical practice.

Apply to join
Schedule an informational meeting

Why Levo Gen 2?

Being part of the Levo Gen 2 Clinical Network means gaining access to an FDA-cleared technology, validated in multiple clinical studies and used across the United States, Europe, and Latin America, with direct support from Centro Tinnitus Montevideo, the official hub for the Spanish-speaking world.

Tinnitus affects more than 15% of the population, and an increasing number of patients are seeking specialized, evidence-based solutions. Integrating Levo Gen 2 into your clinic or medical center allows you to:

    Scientifically validated

    A clinically validated solution, FDA-cleared in the United States and backed by over 20 years of research.

    FDA-cleared and evidence-based

    Levo Gen 2 is grounded in neuroscience and audiology research, with FDA 510(k) clearance supporting its use as a clinical sound therapy for tinnitus.

    Clinical evidence

    Differentiation and prestige

    Stand out as a leader in tinnitus therapy by offering a technology currently available only in select specialized centers.

    Levo Gen 2 Clinical Network

    Integrate precision technology backed by clinical guidance and support. Elevate the patient experience.

    Join the clinical network

    Continuous clinical support

    Enhance the therapeutic relationship with a therapy that integrates precision technology and ongoing clinical support.

    Schedule a meeting

    We’ll define the integration model together (referral, co-management, or in-clinic integration).

    Schedule a meeting

    What does the platform offer for professionals?

    The Levo Gen 2 platform delivers a comprehensive clinical ecosystem designed to streamline clinical practice and enhance the patient experience:

    Integrated clinical software with patient history and progress tracking

    Sound synthesis system for designing the personalized acoustic prescription

    Real-time dashboards and progress indicators

    Continuous learning platform for the desensitization process

    Ongoing clinical and technical support

    Levo Gen 2

    Learn more about the therapy and its clinical approach

    Ways to join the Clinical Network

    There are different ways to participate in the Levo Gen 2 Clinical Network, depending on the profile of the professional or center:

    Specialized referral

    The center identifies patients with tinnitus and refers them to the LevoMedical team for comprehensive evaluation and therapy.

    Shared care / Co-management

    The patient is evaluated at the local center, and therapy is managed in collaboration with the CTM team, with shared follow-up throughout the process.

    Full integration

    The professional incorporates Levo Gen 2 into their practice, supported by LevoMedical team through ongoing clinical and technical guidance.

    Apply to join
    Schedule an informational meeting

    Contact

    Briefly tell us about your case, and a member of our clinical team will get back to you to coordinate the first step.

    What happens after you submit the form?

    • We review your submission and propose available time slots for your evaluation.

    • If appropriate, we send you an initial questionnaire to better understand your hearing profile.

    • We guide you on the consultation format (in-person or remote) and the next steps.



    Coming Soon. Levo Gen 2 is currently not available in the US, pending FDA 510(k) Clearance. Levo Gen 1 is still available in the US.